Posted in | News | Nanomaterials | Nanoanalysis

Zetasizer Nano ZS Used to Characterize Nanoparticles in Ecotoxicology Study

Associate Professor James F. Ranville, from the Department of Chemistry and Geochemistry at the Colorado School of Mines, is using a Zetasizer Nano ZS from Malvern Panalytical to characterize nanoparticles as part of an ecotoxicology study.

Designed to quantitatively detect, characterize and assess the environmental health and safety of metal and metal oxides such as nanosilver, the study aims to uncover what happens when these nanomaterials are released into environments such as our water supply and stomach fluids following ingestion. By employing the Zetasizer Nano's dynamic light scattering (DLS) capabilities as an online detector for a flow field flow fractionation-Inductively coupled plasma-mass spectrometry system (Fl FFF-DLS-ICP_MS), Assoc Prof Ranville has been able to distinguish between nanoparticles, ions and aggregates in multi-modal (mixed sized) samples.

"It is now standard procedure to use DLS in a batch mode for the initial analysis of nanoparticles," said Assoc Prof Ranville. "The technique is recognized as being limited for mixed size samples. Likewise the Fl FFF method, which separates a sample by size using a hydrodynamic cross-flow generated field, can also produce flawed results. In the normal-mode of FFF operation, small particles elute before larger ones, and dissolved ions elute almost immediately. However, when dealing with nano sized particles, where stability can be an issue, some may become aggregated and reversibly 'stick' to the membrane during FFF, resulting in a delay in the elution out of the FFF. By coupling DLS with FFF, these limitations can be overcome. As well as delivering highly resolved peak separation following FFF, DLS will also act as verification of the FFF results, distinguishing interacting small species mistakenly identified as large particles."

James F. Ranville describes nanotechnology as an exploding industry with huge growth forecast over next ten years. He believes that we don't yet know enough about the behavior of nanoparticles, and that we require new methods of discovery in order to have a robust means to assess any potential for harm. In particular he highlights the need to assess a material's dose response i.e. the amount required to produce a response in a biological organism, when the nanoparticle contains elements that are considered toxic, for example cadmium containing quantum dots.

As science continues to explore deeper into the realms of nanotechnology and nanomaterials, it becomes necessary for instruments to deliver better, more highly resolved results within these ranges. The Zetasier Nano ZS is part of the Malvern Panalytical Zetasizer range and can deliver particle size analysis in the 0.3 nm - 10 µm range, zeta potential in the 3.8 nm - 100 µm range, and molecular weight in the 342 - 2x107 Da range.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Malvern Panalytical. (2019, February 12). Zetasizer Nano ZS Used to Characterize Nanoparticles in Ecotoxicology Study. AZoNano. Retrieved on November 21, 2024 from https://www.azonano.com/news.aspx?newsID=23618.

  • MLA

    Malvern Panalytical. "Zetasizer Nano ZS Used to Characterize Nanoparticles in Ecotoxicology Study". AZoNano. 21 November 2024. <https://www.azonano.com/news.aspx?newsID=23618>.

  • Chicago

    Malvern Panalytical. "Zetasizer Nano ZS Used to Characterize Nanoparticles in Ecotoxicology Study". AZoNano. https://www.azonano.com/news.aspx?newsID=23618. (accessed November 21, 2024).

  • Harvard

    Malvern Panalytical. 2019. Zetasizer Nano ZS Used to Characterize Nanoparticles in Ecotoxicology Study. AZoNano, viewed 21 November 2024, https://www.azonano.com/news.aspx?newsID=23618.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.